A practical approach to diagnosis and management of Gaucher's disease

Bailliere's Clinical Haematology

Volumn 10, Issue 4, 1997, Pages 817-838

  Mistry, P K ^a   Abrahamov, A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Glucocerebrosidase mutations; Leukocyte acid glucosidase; Mannose terminated glucocerebrosidase; Splenectomy

Indexed keywords

ALGLUCERASE; GLUCOSYLCERAMIDASE;

DISEASE ACTIVITY; ENZYME REPLACEMENT; ENZYME THERAPY; GAUCHER DISEASE; GENE LOCUS; GENOTYPE; HETEROZYGOTE DETECTION; IMMEDIATE TYPE HYPERSENSITIVITY; LEUKOCYTE; PHENOTYPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW;

EID: 0031437155     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80042-X     Document Type: Review

References (88)

1. Abrahamov A Elstein D Gross-Tsur V Gaucher's disease variant characterised by progressive calcification heart valves and unique genotype Lancet 346 1995 1000 1003
2. Anonymous To affinity and beyond Nature Genetics 14 1996 367 370
3. Balicki D Beutler E Gaucher disease Medicine 74 1995 305 323
4. Barranger JA Ginns EI Glucosylceramide lipidosis: Gaucher disease Scriver CR Beaudet AL Sly WS Valla D Metabolic Basis of Inherited Disease 1989 McGraw-Hill New York 1677 1698
5. Barton NW Brady RO Di Bisceglie AM Replacement therapy for inherited enzyme deficiency—macrophage targeted glucocerebrosidase for Gaucher's disease New England Journal of Medicine 324 1991 1464 1470
6. Bell RS Mankin HJ Doppelt SH Osteomyelitis in Gaucher disease Journal of Bone and Joint Surgery 68A 1986 1380 1388
7. Bembi B Zanatta M Carrozzi M Enzyme replacement treatment in type 1 and 3 Gaucher's disease Lancet 344 1994 1679 1682
8. Beutler E Gaucher disease as a paradigm of current issues regarding single gene mutations of humans Proceedings of the National Academy of Science USA 90 1993 5384 5390
9. Beutler E Kuhl W Detection of the defect of Gaucher's disease and its carrier state in peripheral blood leucocytes Lancet I 1970 612 613
10. Beutler E Kuhl W The diagnosis of adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leucocytes Journal of Laboratory and Clinical Medicine 76 1970 747 755
11. Beutler E Saven A Misuse of marrow examination in diagnsosis of Gaucher disease Blood 76 1990 646 648
12. Beutler E Gelbart T Gaucher disease mutations in non-Jewish patients British Journal of Haematology 85 1993 401 405
13. Beutler E Garber AM Alglucerase for Gaucher's disease. Dose, costs and benefits PharmacoEconomics 5 1994 453 459
14. Beutler E Gelbart T Erroneous assignment of Gaucher disease genotype as a consequence of a complete gene deletion Human Mutations 4 1995 212 216
15. Beutler E Grabowski GA Gaucher disease Scriver CR Beudet A Sly WS Valle D Molecular and Metabolic Bases of Inherited Disease 7th edn 1995 McGraw-Hill New York 2641 2692
16. Beutler E Gelbart T Glucocerebrosidase (Gaucher disease) Human Mutation 8 1996 207 213
17. Beutler E Gelbart T West C The facile detection of nt 1226 mutation of glucocerebrosidase by ‘mismatch’ PCR Clinica Chimica Acta 194 1990 161 166
18. Beutler E Kuhl W Matsumoto F Acid hydrolases in leucocytes and platelets in normal subjects and in patients with Gaucher's disease Journal of Experimental Medicine 143 1976 975 980
19. Beutler E Kay A Saven P Enzyme replacement therapy for Gaucher disease Blood 78 1991 1183 1189
20. Bove K Daughtery C Grabowski GA Pathologic findings in Gaucher disease Type 2 patients following enzyme therapy Human Pathology 26 1995 104 105
21. Brady RO Enzyme replacement therapy for patients with type 3 Gaucher disease Fourth National Gaucher Foundation Conference Nov. 6–7. Philadelphia 1994
22. Brady RO Kanfer JN Shapiro D Metabolism of glucocerebrosides. II Evidence of an enzymatic deficiency in Gaucher's disease Biochemistry and Biophysics Research Communications 18 1965 221 225
23. Brady RO Barton NW Grabowski GA The role of neurogenetics in Gaucher's disease Archives of Neurology 10 1993 1212 1224
24. Busche G Majewski H Schlue J Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph positive chronic myeloid leukaemia Virchows Archiv 430 1997 139 148
25. Carlson DE Bussutil RW Gindici TA Orthotopic liver transplantation in the treatment of complication of type 1 Gaucher disease Transplantation 49 1990 1192 1194
26. Cohen Y Elstein D Abrahamov A HCG contamination of alglucerase: clinical implication in low dose regimend American Journal of Haematology 47 1994 235 236
27. Conradi NG Sourander P Nilsson O Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies Acta Neuropathologica 65 1984 99 109
28. Cox TM Mistry PK Splenectomy in Gaucher disease Aerts JM Goudsmit R Tager JM Proceedings of the First EWGGD Workshop 1995 Publ Durkkerij Universiteit van Amsterdam 82
29. Dahl N Lagerstrom M Erikson A Gaucher disease type 3 (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene American Journal of Human Genetics 47 1990 275 278
30. Dawson A Elias DJ Rubenson D Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome Annals of Internal Medicine 125 1996 901 904
31. Elstein D Hadas-Halpern I Azun Y Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurement Journal of Ultrasound Medicine 16 1997 209 211
32. Erikson A Gaucher disease: Norrbottnian type 3. Neuropathological aspects of clinical patterns and treatment Acta Paediatrica Scandinavica 326 1986 1 42
33. Figueroa ML Rosenbloom SE Kay AC A less costly regimen of alglucerase to treat Gaucher's disease New England Journal of Medicine 327 1992 1632 1636
34. Fleishner PR Aufses AH Grabowski GA A 27-year experience with splenectomy for Gaucher's disease American Journal of Surgery 161 1991 69 75
35. Genzyme Circular to treating physicians dated 13.3.96 1996 Genzyme Corp, One Kendall Square
36. Glenn D Turston D Garner P Comparison of magnetic resonance imaging and ultrasound in evaluating liver size in Gaucher patients Acta Haematologica 92 1994 187 189
37. Goldblatt J Sacks S Dall D Total hip arthroplasty in Gaucher's disease. Long-term prognosis Clinical Orthopedics 228 1988 94
38. Grabowski GA Current issues in enzyme therapy for Gaucher disease Drugs 52 1996 159 167
39. Grabowski GA Goldblatt J Dinur T Genetic heterogenity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from neuronopathic and non-neuronopathic patients American Journal of Medical Genetics 21 1985 529 549
40. Grabowski GA Barton NW Pastores G Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources Annals of Internal Medicine 122 1995 33 39
41. Harats D Pauzner R Elastein D Pulmonary hypertension in two patients with type 1 Gaucher disease while on alglucerase therapy Acta Haematology 98 1997 47 50
42. Harzer K Enzymatic screening for Gaucher disease by assay of beta-glucocerebrosidase in white blood cells Aerts JM Goudsmit R Tager JM Proceedings of the First Workshop of EWGGD 1995 Publ Drukkerij Universiteit van Amsterdam Cambridge, MA 02139, USA 43
43. Hollak CE van Weely S van Oers MHJ Marked elevation of plasma chitotriosidase activity in Gaucher's disease Journal of Clinical Investigation 93 1994 1288 1292
44. Hollak CE Aerts JM Gudsmit R Individualized low-dose alglucerase therapy for type 1 Gaucher's disease Lancet 345 1995 1474 1478
45. (in press) Hollak CE American Journal of Medicine 1997
46. Horowitz M Tzuri G Eyal N Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients American Journal of Human Genetics 53 1993 921 930
47. Johnson LA Hoppel BE Gerard EL Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher's disease Radiology 182 1992 451 455
48. Kaplan P Mazur A Manor O Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase Journal of Paediatrics 129 1996 149 153
49. Latham T Grabowski GA Theophilus BDM Complex alleles of the acid beta-glucosidase gene in Gaucher disease American Journal of Human Genetics 47 1990 79 86
50. Lee RE The pathology of Gaucher disease Desnick RJ Gatt S Grabowski GA A Century of Delineation 1982 Alan R Liss New York 177
51. 54A Lee RE Yousern SA The frequency and type of lung involvement in patients with Gaucher's disease Laboratory Investigations 58 1988
52. Mankin HJ Doppelt SH Rosenberg AE Metabolic bone disease in patients with Gaucher's disease Avioli LV Krane SM Metabolic Bone Disease 1990 WB Saunders Co. Philadelphia 730 752
53. Mistry PK Genotype/phenotype correlation in Gaucher's disease Lancet 346 1995 982 983
54. Mistry PK Cox TM Phenotypic diversity in a pair of identical twins with Gaucher's disease Aerts JM Goudsmit R Tager JM Proceedings of the First Workshop of EWGGD 1995 Publ Drukkerij Universiteit van Amsterdam 62
55. Mistry PK Wraight EP Cox TM Therpeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease Lancet 348 1996 1555 1559
56. 174A Mistry PK Butler P Elstein D Zimran A Regression of hepatomegaly by mannoseterminated glucocerebrosidase Journal of Hepatology 25 supplement 1 1997
57. 124A Mistry PK Butler P Elstein D Zimran A Effect of macrophage targeted glucocerebrosidase on serum lipoproteins in type 1 Gaucher's disease Journal of Hepatology 26 supplement 1 1997
58. Mistry PK Smith SJ Ali M Genetic diagnosis of Gaucher's disease Lancet 339 1992 889 892
59. Mistry PK Davies S Corfield A Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase Quarterly Journal of Medicine 83 1992 541 546
60. 151A Mistry PK Brenton DP Young E Liver transplantation in type 1 Gaucher's disease: role of adjuvant macrophage targeted glucocerebrosidase Journal of Hepatology 26 supplement 1 1997
61. Moscicki RA Adverse reaction and development of antibodies during enzyme replacement therapy NIH Technology Assessment Conference: Gaucher Disease, Current Issues in Diagnosis and Treatment 1995 NIH, Continuing Medical Education Bethesda 123 129
62. Ostlere L Warner T Mennier PJ Treatment of type 1 Gaucher's disease affecting bone with aminohydroxypropylidene biphosphonate (pamidromate) Quarterly Journal of Medicine 79 1991 503 515
63. Pastores GM Gaucher's disease type 1: clinical assessment of bone disease Gaucher Perspectives 2 1994 5 7
64. Pastores GM Sibille AR Grabowski GA Enzyme therapy in Gaucher disease type 1: doasage efficacy and adverse effects in 33 patients treated for 6–24 months Blood 82 1993 408 416
65. Pelini M Boice D O'Neil K Glucocerebrosidase treatment of type 1 Gaucher disease with severe pulmonary involvement Annals of Internal Medicine 121 1994 196 197
66. Pentchev P Brady RO Gal AE Replacement therapy for inherited enzyme deficiency. Sustained clearance of accumulated glucocerebrosidase in Gaucher's disease following infusion of purified glucocerebrosidase Journal of Molecular Medicine 1 1975 73 78
67. Platt FM Neises GR Reinkensmeier G Prevention of lysosomal storage in Tay-Sachs mice treated with N -butyldeoxynojirimycin Science 276 1997 428 431
68. Raghavan SS Topol J Kolodny EH Leucocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease American Journal of Human Genetics 32 1980 158 173
69. Richards SM Olson TA McPherson JM Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase Blood 82 1993 1402 1409
70. Ringden O Groth CG Erikson A Ten years experience of bone marrow transplantation for Gaucher disease Transplantation 59 1995 864 870
71. Rosenthal DI Doppelt SH Mankin HJ Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase Paediatrics 96 1995 629 637
72. Samuel R Katz K Pappapoulos SE Aminohydroxypropylidene biphosphonate (APD) treatment improves the clinical skeltal manifestations of Gaucher's disease Paediatrics 94 1994 385 389
73. Sibille A Eng CM Kim SJ Phenotype/genotype correlation in Gaucher disease: Clinical and therapeutic implications American Journal of Human Genetics 52 1993 1094 1101
74. Sidransky E Bottler A Stubblefield B DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype Human Mutations 3 1994 25 28
75. Tsuji S Choudary PV Martin BM A mutution in the human glucocerebrosidase gene in neuronopathic Gaucher's disease New England Journal of Medicine 316 1987 570 575
76. Turner BM Hischhorn K Properties of beta-glucosidase in cultured fibroblasts from controls and patients with Gaucher disease American Journal of Human Genetics 30 1978 346 358
77. (in press) Vellodi A Gaucher's disease in children Proceedings of the second EWGGD May 1–3, Maastricht 1997
78. Walley AJ Barth ML Ellis I Gaucher's disease in the United Kingdom: screening non-Jewish patients for the two common mutations Journal of Medicine and Genetics 30 1993 280 283
79. Yosipovitch Z Katz K Bone crises in Gaucher disease—an update Israel Journal of Medical Science 26 1990 593 595
80. (in press) Young E Lake B Malone M Gross elevation of plasma chitotriosidase in a patient with normal glucocerebrosidase activity and severe histiocytosis Proceedings of Second EWGGD Workshop May 1–3, Maastricht 1997
81. Zimran A Sorge J Gross E Prediction of severity of Gaucher's disease by identification of mutation at the DNA level Lancet ii 1989 349 352
82. Zimran A Kay A Gelbart T Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients Medicine 71 1992 337 353
83. Zimran A Hollak CE Abrahamov A Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients Blood 82 1993 1107 1109
84. Zimran A Hadas-Halpern I Zevin S Low dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease British Journal of Haematology 85 1993 783 786
85. Zimran A Elstein D Abrahamov A Enzyme replacement therapy in type I and type 3 Gaucher's disease Lancet 345 1994 451 452
86. Zimran A Elstein D Kannai R Low dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype and clinical features on response to treatment American Journal of Medicine 97 1994 3 13
87. Zimran A Elstein D Schiffmann R Outcome of partial splenectomy for type 1 Gaucher disease Journal of Paediatrics 126 1995 596 597
88. Zimran A Elstein D Levy-Lahad E Replacement therapy with iminglucerase for type 1 Gaucher's disease Lancet 345 1995 1479 1480